Pharmaceuticals (Aug 2023)

Exploring the Chemical Properties and Medicinal Applications of Tetramethylthiocycloheptyne Sulfoximine Used in Strain-Promoted Azide–Alkyne Cycloaddition Reactions

  • Matt Timmers,
  • Andi Kipper,
  • Raphael Frey,
  • Stef Notermans,
  • Maksym Voievudskyi,
  • Claire Wilson,
  • Nina Hentzen,
  • Michael Ringle,
  • Clara Bovino,
  • Bernhard Stump,
  • Cristianne J. F. Rijcken,
  • Tina Vermonden,
  • Ingrid Dijkgraaf,
  • Rob Liskamp

DOI
https://doi.org/10.3390/ph16081155
Journal volume & issue
Vol. 16, no. 8
p. 1155

Abstract

Read online

The recently developed compound, tetramethylthiocycloheptyne sulfoximine (TMTHSI), has shown to be a promising strained alkyne for strain-promoted azide–alkyne cycloaddition (SPAAC), metal-free click chemistry. This research explores the properties of TMTHSI-based compounds via three aspects: (1) large-scale production, (2) unique stability in acidic conditions and its subsequent use in peptide synthesis, and (3) the functionalization of antibodies. Here, it is shown that (1) scale-up is achieved on a scale of up to 100 g. (2) TMTHSI is remarkably stable against TFA allowing for the site-specific functionalization of peptides on resin. Finally, (3) the functionalization of an antibody with a model payload is very efficient, with antibody conjugation demonstrating more beneficial features such as a high yield and limited hydrophobicity as compared to other alkyne reagent conjugates. These results illustrate the high potential of TMTHSI for diverse bioconjugation applications, with production already being GMP-compatible and a highly efficient conversion resulting in attractive costs of goods.

Keywords